Anja Cornér

Author PubWeight™ 9.40^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.	Diabetes Care	2009	2.75
2	Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes.	Diabetes Care	2011	1.53
3	Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition.	Diabetes Care	2010	1.21
4	Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.	Diabetes Care	2007	1.16
5	One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress.	Atherosclerosis	2010	1.07
6	Insulin regulation of MCP-1 in human adipose tissue of obese and lean women.	Am J Physiol Endocrinol Metab	2008	0.95
7	Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling.	Radiology	2010	0.80